GlassScriptPrepare for your visit
Vikram Mehta
Family Medicine · Elkhart, IN · NPI 1841293461
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$24,314.41
in general payments reported to CMS, 2019-2025 · $2,545 in 2025
The $2,545 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $2,709.03
- Lilly USA, LLC $2,242.64
- Novo Nordisk INC $1,959.87
- Amgen INC. $1,934.46
- Abbvie INC. $1,567.02
- Glaxosmithkline, LLC. $1,322.18
Drugs and devices associated with these payments
Jardiance Mounjaro Kerendia Omnipod Airsupra Farxiga Trelegy Ellipta Ozempic Breztri Repatha Rybelsus Zepbound
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Vikram Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/265614/vikram-mehta